With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
From cancer research to diagnostic solutions
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The survey inspected ambulances operating throughout the city
Bourgoin early development hub broadens offerings for oral solid dose formulations
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Women of all ages will get round-the-clock access to comprehensive treatment
Subscribe To Our Newsletter & Stay Updated
